Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide—a GLP-1 receptor agonist originally developed for type 2 diabetes—has emerged as a powerful weight loss medication, with clinical trials showing average weight reductions of 15 to 22 percent over 68 weeks. Unlike many weight loss drugs, semaglutide eligibility depends on more than a single metric. PlexusDx evaluates your complete clinical picture to determine whether compounded semaglutide injection therapy aligns with your health status and weight loss objectives.
BMI Thresholds and Weight-Related Health Criteria
The primary qualification for semaglutide use involves body mass index, though the specific threshold varies by clinical context. Individuals with a BMI of 30 or higher qualify for weight loss treatment; those with a BMI of 27 or higher who also carry weight-related health conditions—such as hypertension, type 2 diabetes, or sleep apnea—typically meet eligibility. PlexusDx reviews your current BMI alongside any comorbid conditions that weight loss might improve, ensuring semaglutide therapy targets genuine metabolic and cardiovascular risk.
Weight alone does not determine candidacy; the presence of obesity-related complications strengthens the case for treatment. Patients with elevated blood pressure, abnormal cholesterol, prediabetes, or joint stress from excess weight often see rapid improvements after starting semaglutide. PlexusDx clinicians examine your full metabolic profile to confirm that weight loss therapy addresses real health concerns, not cosmetic preferences.
Medical History and Medication Interactions Matter
Your personal and family medical history shapes semaglutide eligibility. Conditions such as thyroid cancer, medullary thyroid carcinoma, or multiple endocrine neoplasia type 2 contraindicate GLP-1 use. Additionally, a history of severe pancreatitis, gallbladder disease, or uncontrolled mental health conditions requires careful review before starting therapy. PlexusDx conducts a thorough intake assessment to identify any contraindications and ensures semaglutide fits safely within your existing health landscape.
Current medications must align with semaglutide to avoid harmful interactions. Certain diabetes drugs, blood pressure medications, and diuretics may require adjustment once semaglutide therapy begins, as rapid weight loss can shift your dosing needs. PlexusDx coordinates with your primary care provider to review all prescriptions and supplements, confirming that compounded semaglutide injection therapy complements rather than conflicts with your existing medication regimen.
Kidney and Liver Function Assessments
Semaglutide undergoes metabolism involving both renal and hepatic clearance, so baseline kidney and liver function must be adequate. While semaglutide does not require strict dose adjustments for mild-to-moderate renal impairment, PlexusDx requests recent lab work—including creatinine, eGFR, and liver enzymes—to verify that your organ function can safely handle the medication. Severe kidney disease (eGFR below 15) or cirrhosis may limit eligibility or require specialist consultation.
Regular monitoring during therapy ensures your kidneys and liver remain healthy as you lose weight and medications shift. Rapid weight loss can occasionally unmask latent kidney or liver issues, so PlexusDx includes periodic lab check-ins as part of ongoing care. This proactive approach protects your long-term health while maximizing the benefits of semaglutide therapy.
Genetic Insights: Personalize Your Semaglutide Response
Not everyone responds to semaglutide equally, and genetic variation plays a key role. The GLP1R gene (particularly the rs6923761 variant) influences how your body's GLP-1 receptors function and may predict your appetite-suppression response. Similarly, the GIPR rs1800437 variant affects dual GLP-1/GIP pathways, shaping your weight loss trajectory. PlexusDx offers the Precision Peptide Genetic Test—a peptide-pathway assessment that maps 14 metabolic pathways and 49 peptides—helping identify which GLP-1 or combination therapy aligns best with your genetic makeup.
The FTO rs9939609 and MC4R rs17782313 variants relate to baseline appetite drive and satiety signaling, offering clues about your starting dose and expected timeline. By understanding your genetic predispositions before therapy begins, PlexusDx tailors your compounded semaglutide injection plan to your biology. This precision approach increases the likelihood of sustained weight loss and helps you avoid medications less suited to your peptide-pathway profile. The Precision Peptide Genetic Test costs just $99 as an add-on after your first month of treatment.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I need to be diabetic to qualify for semaglutide weight loss therapy?
No. While semaglutide was originally developed for type 2 diabetes, it is now widely prescribed for weight loss in non-diabetic individuals who meet BMI and health criteria. PlexusDx evaluates whether your weight and any weight-related conditions warrant semaglutide, regardless of diabetes status.
What is the minimum BMI to start semaglutide with PlexusDx?
A BMI of 30 or higher generally qualifies. If your BMI is 27–29.9 but you have weight-related health problems like hypertension or sleep apnea, you typically qualify. PlexusDx reviews your full profile to determine eligibility based on metabolic need, not BMI alone.
Will PlexusDx work with my current medications?
PlexusDx conducts a thorough medication review during intake to identify any contraindications or interactions with semaglutide. Your clinician may recommend adjustments to certain drugs once weight loss begins, and coordinates with your primary care provider to ensure safe, integrated care.
Are there age restrictions for semaglutide weight loss therapy?
Semaglutide is approved for adults 18 and older for weight loss. Teens may qualify under special circumstances with pediatric endocrinology input. PlexusDx evaluates each patient's maturity and health context; call to discuss age-specific eligibility if relevant.
Can genetic testing predict whether semaglutide will work for me?
Yes. The PlexusDx Precision Peptide Genetic Test identifies variants in the GLP1R, GIPR, FTO, and MC4R genes that influence your appetite response and weight loss capacity. This $99 add-on test (available after your first month) personalizes your therapy and may reveal whether a dual compound like GLP-Squared suits your genetics better than semaglutide alone.
What if I have a history of pancreatitis or gallbladder disease?
These conditions require careful evaluation. Severe or recent pancreatitis may contraindicate semaglutide, while mild gallbladder disease may be monitored closely. PlexusDx reviews your history in detail and may require specialist clearance before approving compounded semaglutide therapy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding Ozempic Dosing: What is the Maximum You Can Take for Your Weight Loss Journey?
Where is the Best Place to Give Wegovy Shot? Maximizing Comfort and Efficacy